SN.

Smith & Nephew PLC

Health Care First-pass screen £9.7bn

450/1000 Overall fit

AI beneficiary 35% 30

Operating leverage 25% 72

Valuation 25% 30

Downside protection 15% 62

First-pass take

Smith+Nephew demonstrates strong operational leverage with 160bps trading margin expansion and disciplined capital allocation, but lacks AI exposure—CORI surgical robotics are automation, not AI/ML—and valuation multiples are absent from the filing. The healthcare sector offers inherent downside protection, but doesn't fit the AI spending beneficiary thesis.

Flags

no-ai-exposureno-valuation-datastrong-fcf-generationdefensive-healthcaremid-single-digit-growthm-and-a